S everal in vitro studies have documented the fact that neonatal cardiac myocytes possess the various components of the renin-angiotensin system. [1] [2] [3] Sarcomere stretching, applied in an attempt to mimic the in vivo condition of diastolic overloading, is coupled with the cellular release of angiotensin II (Ang II) and the activation of myocyte cellular hypertrophy. 4 However, whether Ang II can promote hypertrophy of adult ventricular myocytes is still controversial. 5, 6 Angiotensin-converting enzyme (ACE) inhibitors prevent myocardial hypertrophy in the overloaded heart, 7 but it is unclear whether this negative trophic effect is due to reduction in ventricular loading, attenuation in the generation of Ang II systemically and locally, or a combination of these mechanisms. The possibility has also been advanced that ACE inhibitors may exert their influence on myocyte growth indirectly through the preservation of bradykinin. 8 Indices of a modest anabolic response of adult feline myocytes to Ang II have been claimed in in vitro preparations. 5 However, changes in myocyte cell volume were not measured, raising the question of the actual impact of Ang II on cell growth.
Adult rat ventricular myocytes express Ang II AT 1 receptors, 9 and radioligand binding assays have identified surface AT 1 receptors on these cells. 10 Conversely, the functional significance of Ang II binding sites on mature myocytes has been questioned, challenging the contention that Ang II may be capable of stimulating growth and mechanical responses. 5, 6, 11 Similar reservations have been made for neonatal myocytes. 12 However, this view is not consistent with in vivo studies demonstrating that Ang II receptors on myocytes increase shortly after coronary artery occlusion, possibly modulating the reactive growth adaptation of the remaining viable cells in the infarcted heart. 10 In this regard, AT 1 receptor antagonists attenuate cardiac hypertrophy in this model. 13 AT 2 receptors may also be expressed in the overloaded myocardium, 14, 15 and this may interfere with the growth-promoting action of AT 1 receptors. 16 The present study sought to determine whether Ang II stimulation of normal adult ventricular myocytes in vitro would result in cellular hypertrophy characterized by changes in myocyte volume and protein content per cell. Moreover, the hypothesis was advanced that the upregulation of Ang II receptors on myocytes after infarction 10, 17 might be coupled with a potentiation and/or acceleration of Ang II-mediated cellular hypertrophy.
Materials and Methods

Coronary Artery Occlusion
Twenty-four male Sprague-Dawley rats (Charles River Breeding Laboratories, North Wilmington, Mass), weighing Ϸ250 g, were used for the surgical induction of myocardial infarction. With the animals under ether anesthesia, thoracotomy via the third left intercostal space was performed, the heart was exteriorized, and the left coronary artery was ligated 1 to 2 mm from its origin. The chest was closed, pneumothorax was reduced by negative pressure, and the animals were allowed to recover. Nine infarcted rats died shortly after the operation. Fifteen sham-operated rats were treated similarly, except that the ligature around the coronary artery was not tied.
The sham operation resulted in no mortality. Animals were killed 3 days after coronary artery occlusion or sham operation.
Global Cardiac Performance
Animals were anesthetized with chloral hydrate (300 mg/kg body wt IP), and the external right carotid artery was exposed and cannulated with a microtipped pressure transducer catheter (Millar SPR-249) connected to an electrostatic chart recorder (Gould ES 2000). After arterial blood pressure was monitored, the catheter was advanced into the left ventricle for the evaluation of left ventricular pressures, ϩdP/dt, and ϪdP/dt. Subsequently, a second catheter (Millar SPR-595), with a 120°curved tip, was inserted in the right jugular vein and advanced through the superior vena cava and the right atrium into the right ventricular chamber for the measurements of central venous pressure, right ventricular pressures, and dP/dt. Thus, measurements were made of systemic arterial and venous blood pressures, ventricular pressures, and dP/dt in the closed-chest preparation. 9, 10, 18 
Myocyte Isolation
At the end of the hemodynamic determinations, hearts were rapidly excised, and myocytes from the left ventricle were enzymatically dissociated. 9, 10, 18 Hearts were placed on a stainless-steel cannula for retrograde perfusion through the aorta. The solutions were supplements of modified commercial Joklik's MEM (JRH Biosciences). HEPES-MEM contained (mmol/L) NaCl 117, KCl 5.7, NaHCO 3 4.4, KH 2 PO 4 1.5, MgCl 2 17, HEPES 21.1, glucose 11.7, L-glutamine 2, and taurine 10 in addition to amino acids, vitamins, and 21 mU/mL insulin and was adjusted to pH 7.2 with NaOH. This solution was 292 mOsm, isosmolar with rat serum. Resuspension medium was HEPES-MEM supplemented with 0.5% BSA and 0.3 mmol/L calcium chloride, adjusted to 292 mOsm. The cell isolation procedure consisted of 3 main steps: (1) Calcium-free perfusion: Blood washout and collagenase (selected type II, Worthington Biochemical) perfusion of the heart was carried out at 34°C with HEPES-MEM gassed with 85% O 2 /15% N 2 . (2) Mechanical tissue dissociation: After removal of the heart from the cannula, the left ventricle inclusive of the septum was separated and minced. In infarcted hearts, only the spared portion of the ventricle was used. Collagenase-perfused tissue was subsequently shaken in resuspension medium containing collagenase and 0.3 mmol/L calcium chloride. Supernatant cell suspensions were washed and resuspended in resuspension medium. (3) Separation of intact cells: Intact cells were enriched by centrifugation and by discarding the supernatant. This procedure was repeated 4 or 5 times in each preparation to remove nonmyocyte cells, cell debris, and the residual collagenase. Each centrifugation was performed at 30g for 3 minutes. Rectangular, trypan blue-excluding cells constituted nearly 80% of all myocytes. The average number of myocytes obtained from the left ventricle of sham-operated control rats and infarcted rats was 6ϫ10 6 and 3.5ϫ10 6 , respectively. The contribution of interstitial cells was assessed by counting 1000 cells in each left ventricle and then computing from these counts the respective fractions of myocytes and nonmyocytes encountered. Consistent with previous results, 9, 10 nonmyocytes accounted for Ͻ1% of the cell population.
Cell Culture
Myocytes were plated in Petri dishes (Corning), coated with 0.5 g/cm 2 of laminin (Sigma Chemical Co), at a density of 2x10 4 cells/cm 2 . Cells were incubated in serum-free medium (SFM), consisting of Eagle's MEM with nonessential amino acids (Sigma), supplemented with penicillin (100 U/mL), streptomycin (50 g/mL), transferrin (10 g/mL), and BSA (0.1%). Cultures were incubated at 37°C in an atmosphere containing 5% CO 2 . SFM was changed 30 minutes after plating to remove myocytes that did not attach to the dish. Concurrently, Ang II at 10 Ϫ9 mol/L 19, 20 was added in HBSS. An equal volume of HBSS was added to control cultures. Myocytes were exposed to Ang II for 3 and 7 days. Pretreatment with losartan (Merck) at 10 Ϫ7 mol/L and PD123319 (Parke-Davis Pharmaceutical Co) at 10 Ϫ7 mol/L was accomplished by adding these drugs 30 minutes before exposure of cells to Ang II. Specifically, PD123319 at a concentration of 10 Ϫ3 mol/L was dissolved in 100 mmol/L Tris-HCl. The medium, Ang II, losartan, and PD123319 were changed daily. At completion, cells were washed with cold HBSS and were fixed in 10% phosphate-buffered formalin for 15 minutes. Phenylalanine incorporation (10 Ci/mL) was measured in myocytes isolated 3 days after infarction. Cells were cultured in SFM for 24 hours; subsequently, Ang II and phenylalanine were added. Three concentrations of Ang II were used: 10 Ϫ11 , 10 Ϫ9 , and 10 Ϫ7 mol/L. After 24 hours, samples were washed 3 times with HBSS supplemented with 10 mmol/L cold phenylalanine and were fixed with 10% trichloroacetic acid for 1 hour at 4°C. Cells were again washed 3 times with 95% ethanol and redissolved with 1 mL of 0.1N NaOH. These aliquots were used for scintillation counting. Eight separate determinations were performed using 8 distinct cell isolations.
Western Blot
For immunoblot assay of AT 1 receptors, myocytes were lysed with 150 to 200 L of lysis buffer containing the protease inhibitors phenylmethylsulfonyl fluoride (2 mmol/L), aprotinin (1 g/mL), dithiothreitol (5 mmol/L), and Na 3 VO 4 (1 mmol/L). Equivalents of 100 to 125 g of protein were separated by 10% SDS-PAGE. Proteins were transferred on nitrocellulose filters and exposed to rabbit polyclonal anti-human AT 1 receptor antibody (No. 306, 5 g/mL, Santa Cruz). Bound antibodies were detected by peroxidaseconjugated anti-rabbit IgG and ECL reagents (Amersham). AT 1 receptor was detected as a 41-kDa band. This analysis included left ventricular myocytes isolated from 5 sham-operated and 5 infarcted rats killed 3 days after surgery. Western blotting was performed at 6 hours and 3 days after plating.
Structural Properties of Myocytes
Myocyte dimensions were measured with a computerized image analysis system (Jandel Scientific): 100 to 200 binucleated myocytes from each preparation were examined to collect length, width, and area. Moreover, cell volume was derived from these geometric parameters. Cells in cultures assume a cross-sectional area, which resembles a flattened ellipse. The ratio of the minor axis (b) to the major axis (a) of the ellipse was obtained by measuring these parameters in 20 myocytes in each preparation by confocal microscopy (Bio-Rad MRC-1000). Cell volume (V C ) was calculated assuming an elliptical cross section with a major axis that was equivalent to cell width and a minor axis that was computed from the measured ratios. Cell length (L) was measured directly [21] [22] [23] :
The quantitative analysis described above was complemented in some experiments with a direct evaluation of the volume of binucleated myocytes by confocal microscopy. For this purpose, myocytes were stained with FITC (1 g/mL) for 30 minutes at room temperature to visualize the cell cytoplasm and with propidium iodide to label the nuclei. By optical section reconstruction of the entire cell in the z or y plane, the volume of sections, 1 m apart, was collected, and their sum was calculated to yield the total cell volume. Twenty myocytes in each preparation were analyzed in this manner. These cells were randomly sampled by including only binucleated myocytes vertically oriented in the microscopic field.
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Cell Distribution
The distribution of myocytes in each experimental condition was divided according to number of cells in an established range of lengths, cross-sectional areas, and volumes. The range of length used varied from 30 to 150 m. Histogram buckets were established with a size of 3 m, and frequency distribution histograms were constructed by plotting the number of cells on the ordinate and the cell length on the abscissa. A similar approach was followed for the analysis of the distribution of cell cross sections and volumes. The range of cross-sectional areas used varied from 100 to 1500 m 2 , and the histogram bucket was 40 m 2 . Finally, the range of cell volume used varied from 8000 to 100 000 m 3 , and the histogram bucket was 2000 m 3 .
Measurement of Protein Content per Cell
Formalin-fixed myocytes were incubated in PBS containing FITC (0.1 g/mL), propidium iodide (10 g/mL), and RNase A (1 mg/mL) for 30 minutes at room temperature. After staining, cultures were washed in PBS and embedded in Vectashield (Vector Laboratories) to prevent photobleaching during the measurements. Total fluorescence of individual myocytes, which corresponded to the protein content per cell, 24, 25 was determined by confocal microscopy. The intensity of FITC fluorescence was measured by optically sectioning the entire thickness of each myocyte and recording the intensity of fluorescence in each of these sections. These intensities were added to yield the total fluorescence in each myocyte. Staining with propidium iodide was used to identify binucleated myocytes. Fifty myocytes in each culture were measured in this manner.
Data Analysis
All measurements are presented as meanϮSD computed from the average results obtained from each culture; n values for each determination, which correspond to the number of independent cultures, are listed in the text or in the legend to each figure.
Comparisons between 2 values were performed by the unpaired Student t test. Statistical significance in multiple comparisons among independent groups of data, in which ANOVA and the F test indicated the presence of significant differences, was determined by the Bonferroni method. 26 Values of PϽ0.05 were considered to be significant.
Results
Myocardial Infarction and Cardiac Function
Myocardial infarction at 3 days did not alter body weight (sham-operated rats, 285Ϯ30 g, nϭ15; infarcted rats, 264Ϯ35 g, nϭ15) and heart weight (sham-operated rats, 923Ϯ99 mg; infarcted rats, 939Ϯ120 mg). However, infarction was characterized by a 3.0-fold (PϽ0.001) increase in left ventricular end-diastolic pressure and a 30% (PϽ0.00l) decrease in left ventricular systolic pressure ( Figure 1 ). Similarly, left ventricular developed pressure was decreased 45% (PϽ0.001), from 106Ϯ6 to 58Ϯ13 mm Hg. Moreover, left ventricular ϩdP/dt was reduced 41% (PϽ0.00l) and ϪdP/dt was reduced 40% (PϽ0.001) in infarcted hearts. Measurements of right ventricular hemodynamics ( Figure 1 ) showed that right ventricular end-diastolic pressure was elevated 4.5-fold (PϽ0.001), whereas right ventricular systolic pressure and diastolic pressure did not change significantly after infarction. In contrast, ϩdP/dt was reduced 18% (PϽ0.005), and central venous pressure was increased 5.7-fold (PϽ0.001). In summary, myocardial infarction resulted in left ventricular failure and right ventricular dysfunction.
Ang II and Adult Ventricular Myocytes in Culture
A dose of 10 Ϫ9 mol/L Ang II was selected. This concentration was established by performing preliminary studies in postinfarcted myocytes at 24 hours in culture in SFM. These cells were exposed to 3 different doses of Ang II (10 Radioactivity measurements were made 24 hours later. Phenylalanine incorporation per 1000 myocytes was 1882Ϯ198 dpm (nϭ8), 1828Ϯ163 dpm (nϭ8), 1694Ϯ152 dpm (nϭ8), and 1522Ϯ178 dpm (nϭ8) at 10 27 A relevant problem in the analysis of the impact of Ang II on myocytes in vitro concerned the changes in the morphological characteristics of the cells. Myocytes were cylindrical in shape at the time of isolation and plating, but this property was not maintained by the majority of cells in culture. The cell population consisted of a mixture of rod-shaped and rounded myocytes (Figure 2A  and 2B) . Moreover, the proportion of rectangular and rounded cells changed from 2 hours after plating to 3 and 7 days in culture. These values in control myocytes were as follows: platingϭ91.2Ϯ2.9% (nϭ4), 3 daysϭ58.5Ϯ6.1% (nϭ5), and 7 daysϭ49.3Ϯ14.4% (nϭ6). Corresponding values in myocytes after infarction were as follows: platingϭ89.7Ϯ4.6% (nϭ4), 3 daysϭ55.8Ϯ8% (nϭ5), and 7 daysϭ52.0Ϯ8.5% (nϭ6). At 3 and 7 days, most rectangular cells possessed long thin projections that altered the normal appearance of these myocytes ( Figure 2C and 2D), complicating even further the morphometric assessment of cell volume by standard techniques. Since loss of cylindrical configuration was a phenomenon that affected a large fraction of myocytes, cell size was measured separately in rod-shaped and rounded myocytes (see below). This was done to establish whether modifications in cell shape influenced the growth response of myocytes to Ang II stimulation in vitro. Cells maintained in SFM showed changes in the cytoplasmic composition with reduction in the myofibrillar compartment. Although lesser in magnitude, similar aspects have also been observed in the presence of Ang II.
An additional factor in these in vitro experiments involved the loss of contraction of myocytes. Shortly after plating, 80Ϯ6% (nϭ4) of the normal cells in SFM were contracting, but this activity was restricted to 1.3Ϯ0.2% (nϭ4) and 0.4Ϯ0.2% (nϭ4) of the myocytes at 3 and 7 days, respectively. A single daily administration of Ang II at 10 Ϫ9 mol/L did not increase the fraction of contracting myocytes: 3 daysϭ1.1Ϯ0.2% (nϭ4) and 7 daysϭ0.5Ϯ0.3% (nϭ4). Ventricular myocytes isolated from infarcted hearts behaved in a similar manner. Under SFM conditions, 75Ϯ9% (nϭ4) of the cells were contracting at plating, with 1.3Ϯ0.4% (nϭ4) contracting at 3 days and 0.4Ϯ0.1% (nϭ4) contracting at 7 days. After Ang II administration, values at 3 and 7 days were 1.2Ϯ0.2% (nϭ4) and 0.3Ϯ0.3% (nϭ4), respectively. In summary, adult ventricular myocytes changed their configuration and lost their ability to contract in culture, and Ang II did not modify these phenomena.
Myocyte Cell Volume
The alterations of myocyte shape with time in culture required a complex approach for the evaluation of myocyte volume. This parameter was obtained by the product of myocyte cell area (measured by an image analysis system) and cell thickness (obtained by confocal microscopy). Optical sections of myocytes on the z plane by confocal microscopy were used to determine the magnitude of cell flattening (Figure 3) . The ratios of cell thickness to cell width are listed in Table 1 ; greater degrees of flattening were associated with lower ratios. These values were obtained by measuring 20 myocytes in each preparation. In each culture dish, myocyte cell area and width were measured randomly in a minimum of 100 cells to a maximum of 200 cells with an image analyzer. These data, in combination with the cell thickness-to-cell width ratio, were used to compute the volume, cross-sectional area, and length of each cell in this larger myocyte sampling (Figure 4) .
A second methodology was used to evaluate myocyte cell volume in these experiments. Figure 5A illustrates 12 optical sections, 1 m apart, of a control myocyte kept in SFM for 7 days. By this 3-dimensional section reconstruction in the y plane, myocyte volume was assessed and, in this specific case, was found to be 18 000 m 3 . Myocyte cross-sectional area and length were 182 m 2 and 99 m, respectively. An identical determination in a myocyte isolated from an infarcted ventricle and stimulated in vitro by Ang II for 3 days is depicted in Figure 5B . In this cell, optical sectioning included 16 images, 1 m apart, and myocyte volume, cross-sectional area, and length were 37 400 m 3 , 367 m 2 , and 102 m, respectively. Additionally, absolute values of myocyte characteristics were obtained and compared by evaluating the same cell in the y and z planes. For example, the control myocyte shown in Figure 5C and 5D, which was cultured in SFM for 3 days, had the following values: in the y orientation, cell length, cross-sectional area, and volume were 68 m, 244 m 2 , and 16 575 m 3 , respectively. Corresponding values in the z plane were 66 m, 247 m 2 , and 16 320 m 3 . The similarity in these parameters suggested that one evaluation on the y or z plane was sufficiently accurate for the assessment of myocyte cell volume. This approach, however, is very time consuming and was restricted to 20 myocytes in each preparation. In summary, a combination of light and confocal microscopy was used for the morphometric analysis of the size and shape of ventricular myocytes in culture. Figure 6A illustrates the average volume of control myocytes at plating and after exposure to SFM or Ang II for 3 and 7 days.
Ang II and Myocyte Volume in Control Cells
Cells kept in SFM showed no change in volume at 3 days and an 11% (PϽ0.05) decrease at 7 days. In comparison with myocytes maintained in SFM, Ang II administration resulted in a 16% (PϽ0.001) increase in mean cell volume at 7 days. The 3% increase at 3 days did not reach statistical significance. Ang II was capable of preventing the reduction in myocyte size that occurred in SFM with time. As also shown in Figure 6A , the AT 1 receptor blocker, losartan, inhibited Ang II-mediated myocyte growth, whereas the AT 2 receptor antagonist PD123319 had no influence on myocyte volume.
The results in Figure 6A were obtained by combining measurements in rod-shaped and rounded myocytes. This was done because comparable values were found in these 2 cell groups in SFM ( Table 2 . Ang II-treated myocytes at 7 days were 18% larger than the corresponding cells kept in SFM, and this difference was significant (PϽ0.005). In summary, Ang II promoted myocyte hypertrophy through the activation of the AT 1 receptor subtype. Figure 6B illustrates that myocytes from infarcted ventricles underwent some atrophy when placed in SFM. Myocyte volume was reduced by 3% (PϭNS) at 3 days and 13% (PϽ0.01) at 7 days. In comparison with control cells maintained in SFM, the administration of Ang II resulted in a 23% (PϽ0.005) increase in myocyte volume at 3 days. At this interval, Ang II-treated myocytes were 18% (PϽ0.05) larger than freshly isolated cells at plating.
Ang II and Cell Volume of Postinfarcted Myocytes
Seven days of Ang II stimulation resulted in a 15% (PϽ0.05) increase in myocyte volume, although this parameter was essentially identical to that of cells at plating. Losartan blocked Ang II-induced myocyte hypertrophy at 3 and 7 days, whereas PD123319 did not interfere with this response ( Figure 6B ). Measurements of cell size by confocal microscopy in subsets of myocytes confirmed these results (Table 3) .
When the data in Figure 6 were compared, it was apparent that myocytes from infarcted hearts were 19% (PϽ0.05), 13% (PϽ0.05), and 16% (PϽ0.001) larger in volume than cells from sham-operated animals at plating and at 3 and 7 days in SFM, respectively. The addition of Ang II increased this difference at the earlier interval in culture, since cell volume was 35% greater in postinfarcted myocytes than in normal cells at 3 days (PϽ0.001). However, at 7 days after Ang II administration, the variation in cell volume between these two groups of myocytes was 15% (PϽ0.05).
To determine whether the effects of Ang II on normal and postinfarcted myocytes involved the entire cell population or a fraction of myocytes, the changes in the distribution of length, cross-sectional area, and volume of these cells were measured. This analysis included 1540 control cells maintained in SFM for 7 days and 1540 control myocytes exposed to Ang II for the same period. The 7-day interval was selected because no myocyte hypertrophy was found with Ang II at 3 days. Conversely, myocytes from infarcted ventricles were examined at 3 days, since hypertrophy was essentially completed at this time and decreased from 3 to 7 days; 1680 myocytes kept in SFM and 1680 cells treated with Ang II were evaluated. Figure 7 illustrates the ranges of muscle cell lengths, cross-sectional areas, and volumes observed in control myocytes kept in SFM and after Ang II stimulation. In SFM, the distributions of cell cross section and volume were evenly balanced around the mean values, with the majority of cells located close to the means. Ang II treatment modestly shifted to the right the distribution of myocyte cross-sectional areas and volumes. The values of myocyte length were more An identical analysis was performed with myocytes from infarcted hearts. After Ang II administration, there was a change in the cell length distribution, and a comparable phenomenon was noted with respect to myocyte crosssectional area and volume (Figure 8 For control myocytes, cultures were as follows: plating, nϭ5; SFM, nϭ6 at 3 days and nϭ9 at 7 days; Ang II, nϭ6 at 3 days and nϭ8 at 7 days; Ang IIϩLOS, nϭ4 at 3 and 7 days; and Ang IIϩPD, nϭ4 at 3 and 7 days. For postinfarcted myocytes, cultures were as follows: plating, nϭ5; serum-free medium (SFM), nϭ9 at 3 and 7 days; Ang II, nϭ9 at 3 days and nϭ8 at 7 days; Ang IIϩLOS, nϭ4 at 3 days and nϭ7 at 7 days; and Ang IIϩPD, nϭ4 at 3 and 7 days. *PϽ0.05 vs value in SFM; †PϽ0.05 vs value at plating.
(PϽ0.001), from 24.23Ϯ4.84 to 25.27Ϯ5.69 m, which was nearly 50% smaller than the expansion in length of myocytes. A relevant aspect illustrated in Figures 7 and 8 is that the changes in cell volume in each cell group involved only a fraction of the population. The peak of the histogram was lower than in the corresponding SFM control, and the cells were shifted to the right toward higher values. In contrast, the left side of the histogram and the position of its peak remained essentially unchanged. This may imply a partial nonuniform adaptation of myocytes to Ang II. In summary, Ang II resulted in cellular hypertrophy of postinfarcted myocytes, and this response occurred earlier and was of greater magnitude than in control cells.
Expression of AT 1 Receptor in Myocytes
This analysis was performed to establish whether the difference in Ang II receptor density previously shown between control and postinfarcted myocytes in vivo 10, 17 persisted in culture under SFM conditions. The in vitro maintenance of a higher level of AT 1 receptor protein in myocytes surviving an acute myocardial infarction should have influenced the effects of Ang II stimulation on cellular growth. Figure 9 illustrates the changes in AT 1 receptor protein in myocytes obtained from sham-operated and infarcted rats after 6 hours and 3 days in culture in SFM. Postinfarcted myocytes had higher levels of expression of AT 1 receptors than did control cells at both time intervals examined. Densitometrically, there was a 1.8-fold increase at 6 hours (OD: control cellsϭ29Ϯ5, nϭ5; postinfarcted cellsϭ52Ϯ12, nϭ5; PϽ0.005) and a 1.7-fold increase at 3 days (OD: control cellsϭ34Ϯ7, nϭ5; postinfarcted cellsϭ58Ϯ14, nϭ5; PϽ0.01). However, the small differences in each cell group between 6 hours and 3 days in culture were not statistically significant. In summary, AT 1 receptor protein was higher in postinfarcted myocytes than in control cells in culture.
Ang II and Protein Content per Cell
To confirm the ability of Ang II to induce myocyte hypertrophy, the amount of protein per cell was determined by confocal microscopy after staining with FITC. This technique results in the labeling of proteins, and small differences in fluorescence intensity can be detected accurately. 24 Ang II increased this parameter 1% (PϭNS) and 20% (PϽ0.00l) in control myocytes at 3 and 7 days, respectively (Figure 10) . In postinfarcted myocytes, a 28% increase (PϽ0.00l) at 3 days and a 20% increase (PϽ0.05) at 7 days in protein content per cell was noted after Ang II administration. Losartan inhibited the effects of Ang II on both myocyte populations. In contrast, the AT 2 receptor blocker PD123319 did not influence the changes produced by Ang II (Figure 10 ). In summary, Ang II increased the protein level of myocytes, but this phenomenon took place earlier and was enhanced in postinfarcted cells.
Discussion
The results of the present study indicate that Ang II in the nanomolar range was capable of inducing hypertrophy of adult ventricular myocytes in culture in the absence of cellular loading and contractile activity. This response was demonstrated quantitatively by measurements of myocyte volume and protein content per cell. Changes in myocyte size and protein levels were documented by confocal microscopy. Left ventricular myocytes from infarcted hearts showed earlier increases in cell volume and protein content per cell than did control myocytes. Moreover, enlarged postinfarcted myocytes achieved a greater additional magnitude of hypertrophy, suggesting that the growth-promoting effects of Ang II were enhanced in cells surviving an acute myocardial infarct. These adaptations were coupled with activation of surface AT 1 receptors only. AT 2 receptors appeared not to be involved in Ang II-mediated myocyte growth.
Ang II and Myocyte Growth
In the last several years, numerous in vivo 7,9,28 -30 and in vitro [1] [2] [3] [4] [5] [6] studies have characterized the influence of Ang II on ventricular myocytes. Ang II may induce 3 different responses: stimulation of myocyte hypertrophy, 2, 5, 16 improvement in the mechanical behavior and Ca 2ϩ transients of the cells, [31] [32] [33] and activation of myocyte apoptosis. 19, 20, 34 However, the ability of Ang II to affect myocyte contractility 11 and cell growth 5, 6, 12 has been repeatedly challenged in neonatal and adult myocytes. Since the impact of Ang II on myocardial function has been documented in vivo in several model systems 35 and in isolated papillary muscles, 33 the negative observations at the cellular level raise questions about the validity of the preparations. Similarly, the anabolic consequences of Ang II on myocytes have been criticized on the basis of semiquantitative methods that provide no information about the actual changes in myocyte volume. 12 Additionally, alterations in protein content per cell were not measured, and conclusions were drawn on degrees of amino acid incorporation, neglecting the role of Ang II on the catabolic and anabolic states of myocytes over time. Conversely, moderate increases in myocyte protein have been shown in adult quiescent myocytes from normal cats 7 days after the addition of Ang II, 5 although myocyte cell volume was not obtained.
Observations in the present study are consistent with a growth-stimulating capacity of Ang II on ventricular myocytes. Cellular hypertrophy was measured by confocal microscopy, which allowed comparisons between changes in size and protein content in the same cells. Although only binucleated myocytes were analyzed in the present study, this approach permits the evaluation of the volume of mononucleated and multinucleated cells as well. [21] [22] [23] At present, this information can be obtained only by this technique. In the present experiments, cell growth was faster and greater in myocytes from failing infarcted hearts. In spite of a 19% larger volume of freshly isolated myocytes from infarcted hearts, Ang II produced a 40% to 45% higher hypertrophic response in these cells than in control myocytes. The concomitant increase in cytoplasmic protein and myocyte dimension unequivocally indicated cell growth and not dedifferentiation. This latter phenomenon is characterized by a reduction in protein concentration per cell. 35, 36 Importantly, measurements of cell volume by confocal microscopy are not influenced by changes in cell shape. 37 This methodology permits a direct evaluation of cell size.
Some additional comments concerning the interpretation of these findings are in order. The discussion above is based on the changes in volume of myocytes maintained in SFM in the absence and presence of Ang II. However, the lack of Ang II was characterized by a reduction in size of cells from control and postinfarcted hearts, indicating that adult quiescent myocytes in culture are subject to cellular atrophy. From plating to 7 days, the degree of this phenomenon averaged 12% in both groups of myocytes. Seven days of Ang II essentially maintained the original volume of myocytes isolated from sham-operated rats, questioning whether cellular hypertrophy actually occurred. Conversely, postinfarcted myocytes, stimulated for 3 days with Ang II, reached a volume that was not only 23% greater than that for the cells in SFM but also 18% larger than that for myocytes at plating, demonstrating an absolute increase in cell size.
These results were surprising and difficult to interpret. However, quiescent myocytes in vitro may be expected to undergo atrophy, mimicking a condition repeatedly shown in vivo in the presence of attenuated 39 or abolished myocardial loading. 40, 41 Myocytes in SFM are unloaded and do not exhibit contractile activity; these characteristics have been shown to influence the structural organization and relative amount of the myofibrillar compartment of the cytoplasm. 42 Undifferentiated areas of myocyte cytoplasm, characterized by limited myofibrillar structures, have been found in cells maintained in SFM, resembling the morphological aspects of ongoing myocyte atrophy. 40 Although in a more restricted manner, similar aspects have been detected in myocytes exposed to Ang II, confirming that cellular atrophy occurs in vitro. Thus, Ang II may be capable of producing a significant growth response in myocytes, which may be obscured by cellular atrophy under culture conditions. Why Ang II not only induces cellular hypertrophy but also stimulates myocyte apoptosis is complex. 19, 20 Cell death is restricted to a small percentage of the population, 20 whereas cell growth involves a larger fraction of myocytes. This differential response of adult rat ventricular myocytes to Ang II may reflect heterogeneity in the expression of genes that protect cells from apoptosis or facilitate this process. 43 For example, the low level of apoptosis detected in the failing canine heart is associated with an increase in the number of cells labeled by p53. 44 This transcription factor is activated by Ang II, 45 and this may lead to a reduction in the Bcl-2/Bax protein ratio in the cytoplasm, enhancing the susceptibility of cells to trigger their suicide program.
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AT 1 and AT 2 Receptor Subtypes and Myocyte Hypertrophy
Ventricular myocytes possess 2 classes of pharmacologically distinct and functionally active surface Ang II receptors. Neonatal cardiac myocytes exhibit both AT 1 and AT 2 receptor subtypes, 46, 47 and each subtype accounts for 50% of the specific binding. 46 Additionally, mechanical stretch in vitro increases the expression of AT 1 and AT 2 receptors by Ϸ3-fold. 48 Similarly, pathological states of the adult heart characterized by sudden increases in diastolic wall stress and myocyte stretching result in upregulation of Ang II receptors. Such a response occurs acutely after infarction, in which the density of Ang II receptors on the spared myocytes increases by nearly 50% and 100% at 3 days 17 and 7 days, 10 respectively. Ventricular dysfunction induced by nonocclusive coronary artery constriction typically shows a 3-to 4-fold augmentation in Ang II receptors on myocytes. 9 However, control myocytes exhibit AT 1 receptors only, 10 and the existence and relative contribution of AT 1 and AT 2 receptor subtypes were not examined under these experimental conditions. The possibility of an upregulation of AT 2 receptors on myocytes has been raised in pressure-overload hypertrophy 14 Figure 8 . Changes in the distribution of cell length, cross-sectional area, and volume in postinfarcted myocytes kept in serum-free medium (SFM) or exposed to angiotensin II (Ang II) for 3 days (SFM, nϭ1680; Ang II, nϭ1680). and in the postinfarcted heart. 49 Unfortunately, the use of myocardial tissue for the preparation of cellular membranes failed to provide unequivocal evidence of surface AT 2 receptor on stressed myocytes.
Results in the present study demonstrate that Ang IIinduced myocyte hypertrophy was mediated by the activation of AT 1 receptors, since the AT 1 antagonist losartan completely inhibited cellular growth and the increase in protein content per cell. Moreover, AT 1 receptor protein was increased in postinfarcted myocytes, which exhibited a greater Ang II-mediated growth response. Conversely, the AT 2 receptor blocker PD123319 failed to modify the effects of Ang II on myocyte hypertrophy. These phenomena were apparent in both control myocytes and myocytes isolated from infarcted hearts. However, the increase in Ang II receptor protein on the viable cells after infarction was associated with an earlier and greater reactive response, pointing to the critical role of the number of AT 1 binding sites in the modulation of cellular growth. The prevailing increase in myocyte length induced by Ang II in postinfarcted myocytes raises the possibility that the growth adaptation obtained in this cell population in vitro maintains the characteristics detected in vivo. In this regard, the elevation in diastolic load on the surviving myocardium after infarction in rats and humans is associated with a predominant lengthening of myocytes, which contributes to ventricular dilation. 30 ACE inhibitors reduce myocyte hypertrophy and cavitary volume after infarction. 30 The nonuniform shift to higher values in the distribution of cell volumes in Ang II-stimulated cultures in the present study strongly suggests that the myocyte population consisted of Ang II-responding and nonresponding cells. The enzymatic dissociation of myocytes with collagenase may alter receptor sites, affecting the capability of cells to perceive the effects of Ang II. This potential artifact may be responsible for the contrasting findings concerning the influence of Ang II on the growth of neonatal and adult ventricular myocytes. Importantly, this technical defect may result in an underestimation of the actual magnitude of myocyte hypertrophy produced by Ang II in vitro and inappropriately may raise questions regarding the significance of the local reninangiotensin system in vivo in the pathological heart.
